Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome

NCT01145612 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

140

Enrollment

INDIV

Sponsor class

Conditions

Marfan Syndrome

Interventions

DRUG: Losartan
DRUG: Atenolol

Sponsor

Forteza, Albert, M.D.

Collaborators

[object Object]